THIEPINO[3,2-B]DIHYDROPYRIDINES AND RELATED COMPOSITIONS AND METHODS
申请人:Ortho-McNeil Pharmaceutical, Inc.
公开号:EP1265903A1
公开(公告)日:2002-12-18
US6420383B1
申请人:——
公开号:US6420383B1
公开(公告)日:2002-07-16
[EN] THIEPINO [3,2-b] DIHYDROPYRIDINES AND RELATED COMPOSITIONS AND METHODS<br/>[FR] THIEPINO [3,2-B] DIHYDROPYRIDINES, ET COMPOSITIONS ET METHODES ASSOCIEES
申请人:ORTHO MCNEIL PHARM INC
公开号:WO2001070748A1
公开(公告)日:2001-09-27
This invention provides novel thiepino[3,2-b]dihydropyridines of the formulae (I, II, V). These compounds are useful as calcium channel antagonists with cardiovascular, antiasthmatic and antibronchoconstriction activity. Thus, this invention also provides pharmaceutical compositions, as well as methods, for preventing and treating disorders such as hypersensitivity, allergy, asthma, bronchospasm, dysmenorrhea, esophageal spasm, glaucoma, premature labor, urinary tract disorders, gastrointestinal motility disorders and cardiovascular disorders.
Thiepino[3,2-b]dihydropyridines and related compositions and methods
申请人:Ortho-McNeil Pharmaceutical, Inc.
公开号:US06420383B1
公开(公告)日:2002-07-16
This invention provides novel thiepino[3,2-b]dihydropyridines of the following formulae:
These compounds are useful as calcium channel antagonists with cardiovascular, antiasthmatic and antibronchoconstriction activity. Thus, this invention also provides pharmaceutical compositions, as well as methods, for preventing and treating disorders such as hypersensitivity, allergy, asthma, bronchospasm, dysmenorrhea, esophageal spasm, glaucoma, premature labor, urinary tract disorders, gastrointestinal motility disorders and cardiovascular disorders.